Section Arrow
Quote
IART.NASDAQ
- Integra LifeSciences Holdings Corp
Quotes are at least 15-min delayed:2025/10/23 21:42 EDT
Regular Hours
Last
 15.88
+0.42 (+2.72%)
Day High 
15.93 
Prev. Close
15.46 
1-M High
16.35 
Volume 
965.59K 
Bid
15.73
Ask
16.03
Day Low
15.26 
Open
15.46 
1-M Low
12.8 
Market Cap 
1.20B 
Currency USD 
P/E 78.9 
%Yield -- 
10-SMA 14.65 
20-SMA 14.4 
50-SMA 14.62 
52-W High 27.13 
52-W Low 11.06 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.54/2.45
Enterprise Value
2.57B
Balance Sheet
Book Value Per Share
13.33
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.61B
Operating Revenue Per Share
19.80
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
QSIQuantum-Si2.2--0.000%-- 
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
PMIPicard Medical Inc13.2+0.03+0.23%-- 
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
Quotes are at least 15-min delayed：2025/10/23 21:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.